Literature DB >> 18067129

Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.

Maaike A van der Aa1, Eero Pukkala, Jan Willem W Coebergh, Ahti Anttila, Sabine Siesling.   

Abstract

With respect to cervical cancer management, Finland and the Netherlands are comparable in relevant characteristics, e.g., fertility rate, age-of-mother at first birth and a national screening programme for several years. The aim of this study is to compare trends in incidence of and mortality from cervical cancer in Finland and the Netherlands in relation to the introduction and intensity of the screening programmes. Therefore, incidence and mortality rates were calculated using the Cancer Registries of Finland and the Netherlands. Data on screening intensity were obtained from the Finnish Cancer Registry and the Dutch evaluation centre at ErasmusMC-Rotterdam. Women aged 30-60 have been screened every 5 years, in Finland since 1992 and in the Netherlands since 1996. Screening protocols for smear taking and referral to the gynaecologist are comparable. Incidence and mortality rates have declined more in Finland. In 2003, age-adjusted incidence and mortality in Finland were 4.0 and 0.9 and in the Netherlands 4.9 and 1.4 per 100,000 woman-years, respectively. Excess smear use in the Netherlands was estimated to be 24 per 1,000 women during a 5-year interval compared to 121 in Finland. The decline in mortality in Finland seems to be almost completely related to the screening programme whereas in the Netherlands it was initially considered to be a natural decline. Differences in risk factors might also play a role: the Netherlands has higher population density and higher percentages of immigrants and (female) smokers. The greater excess smear use in Finland might also have affected incidence.

Entities:  

Mesh:

Year:  2008        PMID: 18067129     DOI: 10.1002/ijc.23276

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters.

Authors:  Jacqueline M Vink; Folkert J van Kemenade; Chris J L M Meijer; Mariel K Casparie; Gerrit A Meijer; Dorret I Boomsma
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

2.  Incidence and mortality trend of cervical cancer in 11 cancer registries of china.

Authors:  Tao Lei; Wei-Min Mao; Tong-Hai Lei; Li-Qiong Dai; Luo Fang; Wan-Qing Chen; Si-Wei Zhang
Journal:  Chin J Cancer Res       Date:  2011-03       Impact factor: 5.087

3.  Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study.

Authors:  D Mesher; A Szarewski; L Cadman; H Cubie; H Kitchener; D Luesley; U Menon; G Hulman; M Desai; L Ho; G Terry; A Williams; P Sasieni; J Cuzick
Journal:  Br J Cancer       Date:  2010-03-30       Impact factor: 7.640

4.  Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years.

Authors:  Zhezhou Huang; Ying Zheng; Wanqing Wen; Chunxiao Wu; Pingping Bao; Chunfang Wang; Weijian Zhong; Yu-Tang Gao; Fan Jin; Yong-Bing Xiang; Xiao-Ou Shu; Alicia Beeghly-Fadiel
Journal:  Eur J Cancer       Date:  2016-05-26       Impact factor: 9.162

5.  Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.

Authors:  Romy van Baars; Heather Griffin; Zhonglin Wu; Yasmina Jay Soneji; Miekel van de Sandt; Rupali Arora; Jacolien van der Marel; Bram Ter Harmsel; Robert Jach; Krzysztof Okon; Hubert Huras; David Jenkins; Wim Quint; John Doorbar
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

6.  Incidence and mortality of cervical cancer in Vietnam and Korea (1999-2017).

Authors:  Kim Ngoc Tran; Yoon Park; Byung-Woo Kim; Jin-Kyoung Oh; Moran Ki
Journal:  Epidemiol Health       Date:  2020-12-16

7.  Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.

Authors:  A Waldmann; S Nolte; M A Weinstock; E W Breitbart; N Eisemann; A C Geller; R Greinert; B Volkmer; A Katalinic
Journal:  Br J Cancer       Date:  2012-01-31       Impact factor: 7.640

8.  Uptake in cancer screening programmes: a priority in cancer control.

Authors:  D P Weller; C Campbell
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

9.  New insights into cervical cancer screening.

Authors:  Jonathan D Boone; Britt K Erickson; Warner K Huh
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

Review 10.  Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis.

Authors:  Hung N Luu; Kristina R Dahlstrom; Patricia Dolan Mullen; Helena M VonVille; Michael E Scheurer
Journal:  Cancer Med       Date:  2013-04-21       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.